Nayantara Seneviratne, MD

Offices

1 location · East Alabama Endocrinology, P.C. · 7 clinicians in this group

Looking this up.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Seneviratne’s office at (706) 256-2525 to ask if they take your plan before you enroll.

California Medical Board record

Licence A67095 · Current

Licensed to practise in California · since 1998 · expires 2026-12-31 · Emory University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$25,193

Medicare paid this office $25,193 for 103 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Return visit (30+ min)	55	$7,005	$121
Long return visit (40+ min)	37	$6,689	$172
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	79	$1,300	$15

Who their Medicare patients are

103 Original Medicare patients in 2024. Average age 74 · Women 76% · Health risk score 1.22. At or below the middle of the specialty; the typical endocrinology clinician is at 1.46.

Conditions among them: High blood pressure 72% · Diabetes 46% · Coronary heart disease 33% · Chronic kidney disease 25% · Depression 23% · Cancer 21% · Atrial fibrillation 14% · Stroke 12%.

The office billed $96,895, Medicare allowed $31,607 and paid $25,193; for 1,196 services of 12 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	103	1,196	74	1.22	$96,895	$25,193
2023	85	885	74	1.46	$61,802	$24,849
2022	67	197	75	1.07	$45,670	$21,127
2021	82	249	75	1.30	$64,280	$31,094
2020	62	147	73	1.38	$39,850	$16,674
2019	75	214	73	1.33	$54,780	$22,570
2018	70	192	76	1.54	$45,200	$17,189
2017	65	192	75	1.28	$46,490	$18,949
2016	71	180	75	1.42	$49,550	$21,593
2015	60	141	73	1.49	$37,680	$16,568
2014	38	72	73	1.37	$20,875	$10,526

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 4 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	38	$6,488	$147
Return visit (30+ min)	45	$6,328	$111
Short return visit (20+ min)	12	$1,350	$71
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	13	$545	$29

2022: 3 services

Sort by

Original Medicare services billed in 2022

Return visit (30+ min)	41	$8,434	$107
Long return visit (40+ min)	31	$7,668	$153
Short return visit (20+ min)	13	$1,363	$85

2021: 6 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	38	$11,520	$158
Return visit (30+ min)	50	$9,413	$116
New patient visit (60+ min)	20	$3,960	$198
New patient visit (45+ min)	19	$2,731	$144
Short return visit (20+ min)	13	$1,128	$81
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	12	$799	$32

2020: 3 services

Sort by

Original Medicare services billed in 2020

Long return visit (40+ min)	33	$6,666	$126
Return visit (30+ min)	32	$4,621	$96
New patient visit (60+ min)	13	$2,343	$180

2019: 4 services

Sort by

Original Medicare services billed in 2019

Long return visit (40+ min)	41	$10,174	$129
Return visit (30+ min)	37	$5,838	$93
New patient visit (45+ min)	11	$1,653	$150
Short return visit (20+ min)	15	$1,322	$70

2018: 5 services

Sort by

Original Medicare services billed in 2018

Return visit (30+ min)	38	$5,762	$89
Long return visit (40+ min)	25	$4,802	$120
New patient visit (45+ min)	13	$1,758	$135
Short return visit (20+ min)	13	$796	$50
Injection of drug or substance under skin or into muscle	14	$389	$16

2017: 5 services

Sort by

Original Medicare services billed in 2017

Return visit (30+ min)	32	$6,000	$98
Long return visit (40+ min)	29	$4,962	$118
Short return visit (20+ min)	21	$1,869	$69
New patient visit (45+ min)	13	$1,847	$142
Injection of drug or substance under skin or into muscle	12	$406	$25

2016: 4 services

Sort by

Original Medicare services billed in 2016

Long return visit (40+ min)	34	$8,174	$134
Return visit (30+ min)	35	$5,710	$102
New patient visit (45+ min)	19	$2,925	$154
New patient visit (60+ min)	13	$2,480	$191

2015: 4 services

Sort by

Original Medicare services billed in 2015

Long return visit (40+ min)	23	$5,653	$135
New patient visit (60+ min)	21	$3,874	$184
Return visit (30+ min)	17	$2,446	$98
New patient visit (45+ min)	15	$2,013	$134

2014: 3 services

Sort by

Original Medicare services billed in 2014

New patient visit (60+ min)	25	$4,751	$190
Long return visit (40+ min)	15	$2,692	$135
Return visit (30+ min)	11	$1,213	$101

Drugs they prescribed that Part D paid

$181,779

Pharmacies billed $181,779 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 358) in 2024. At or below the middle of the specialty; the typical endocrinology clinician is at 0%.

128 generic and 211 brand-name prescriptions · $181,779 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Januvia	31	$44,207	$1,426
Ozempic	26	$35,612	$1,370
Jardiance	21	$27,935	$1,330
Tresiba Flextouch U-100	18	$8,430	$468
Synthroid	26	$3,154	$121

See all 10 drugs

Sort by

Every Part D drug this clinician prescribed

Januvia	31	$44,207	$1,426
Ozempic	26	$35,612	$1,370
Jardiance	21	$27,935	$1,330
Tresiba Flextouch U-100	18	$8,430	$468
Synthroid	26	$3,154	$121
Humalog Kwikpen U-100	14	$2,765	$198
Levothyroxine	28	$328	$12
Metformin	20	$324	$16
Repaglinide	16	$198	$12
Atorvastatin	11	$131	$12

Year by year

Sort by

Part D prescribing by year

2024	358	129	0% (0)	59%	$181,779
2023	779	113	0% (0)	54%	$413,083
2022	909	107	0% (0)	55%	$524,203
2021	769	114	0% (0)	55%	$364,233
2020	659	93	0% (0)	57%	$232,543
2019	742	82	0% (0)	54%	$235,537
2018	734	88	None	55%	$200,029
2017	626	78	0% (0)	51%	$197,390
2016	577	79	None	48%	$135,893
2015	383	59	0% (0)	48%	$91,640
2014	264	48	0% (0)	44%	$49,688
2013	19	12	0% (0)	None	$2,943

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 21 drugs

Sort by

Part D drugs prescribed in 2023

Januvia	51	$69,413	$1,361
Ozempic	42	$60,665	$1,444
Trulicity	24	$39,965	$1,665
Jardiance	24	$37,836	$1,577
Tradjenta	12	$18,377	$1,531
Humalog Kwikpen U-100	34	$18,017	$530
Tresiba Flextouch U-100	33	$17,285	$524
Novolog Flexpen	12	$10,679	$890
Lantus Solostar	17	$7,408	$436
Synthroid	58	$6,402	$110
Nano 2nd Gen Pen Needle	38	$3,963	$104
Testosterone	14	$2,581	$184
Repaglinide	44	$1,937	$44
Ultra-Fine Mini Pen Needle	21	$1,604	$76
Liothyronine	19	$980	$52
Levothyroxine	51	$727	$14
Metformin	32	$514	$16
Metformin Hcl Er	17	$316	$19
Methimazole	11	$166	$15
Atorvastatin	23	$157	$7
Losartan	12	$140	$12

2022: 23 drugs

Sort by

Part D drugs prescribed in 2022

Forteo	37	$156,378	$4,226
Januvia	64	$73,611	$1,150
Trulicity	41	$58,403	$1,424
Jardiance	36	$51,262	$1,424
Ozempic	26	$26,538	$1,021
Farxiga	16	$16,301	$1,019
Humalog Kwikpen U-100	22	$13,360	$607
Tresiba Flextouch U-100	15	$10,689	$713
Levemir Flextouch	18	$10,437	$580
Lantus Solostar	15	$8,925	$595
Synthroid	73	$5,716	$78
Nano 2nd Gen Pen Needle	40	$3,892	$97
Raloxifene	11	$2,197	$200
Ultra-Fine Mini Pen Needle	20	$1,347	$67
Liothyronine	24	$862	$36
Metformin Hcl Er	41	$810	$20
Levothyroxine	63	$746	$12
Atorvastatin	43	$673	$16
Repaglinide	21	$658	$31
Metformin	43	$560	$13
Glimepiride	15	$411	$27
Methimazole	18	$326	$18
Losartan	15	$194	$13

2021: 20 drugs

Sort by

Part D drugs prescribed in 2021

Forteo	13	$52,038	$4,003
Trulicity	32	$44,609	$1,394
Jardiance	51	$40,982	$804
Januvia	39	$34,924	$895
Victoza 3-Pak	16	$24,022	$1,501
Ozempic	16	$23,458	$1,466
Tradjenta	16	$17,608	$1,100
Lantus Solostar	19	$14,197	$747
Soliqua 100-33	17	$13,928	$819
Farxiga	12	$7,926	$660
Synthroid	56	$4,471	$80
Basaglar Kwikpen U-100	12	$2,701	$225
Nano 2nd Gen Pen Needle	23	$2,164	$94
Repaglinide	32	$1,184	$37
Metformin Hcl Er	40	$924	$23
Levothyroxine	40	$639	$16
Atorvastatin	35	$548	$16
Metformin	55	$518	$9
Levoxyl	18	$147	$8
Methimazole	13	$92	$7

2020: 21 drugs

Sort by

Part D drugs prescribed in 2020

Januvia	37	$39,186	$1,059
Jardiance	40	$27,594	$690
Victoza 3-Pak	17	$20,192	$1,188
Levemir Flextouch	20	$15,634	$782
Tradjenta	16	$15,378	$961
Lantus Solostar	16	$13,815	$863
Humalog Kwikpen U-100	12	$13,324	$1,110
Levemir	13	$5,213	$401
Risedronate	14	$4,808	$343
Synthroid	60	$4,291	$72
Raloxifene	13	$1,432	$110
Ultra-Fine Nano Pen Needle	13	$1,229	$95
Levothyroxine	46	$1,053	$23
Metformin Hcl Er	30	$903	$30
Atorvastatin	23	$546	$24
Levoxyl	33	$503	$15
Liothyronine	13	$439	$34
Hydrocortisone	11	$428	$39
Metformin	47	$415	$9
Lisinopril	12	$166	$14
Losartan	12	$142	$12

2019: 19 drugs

Sort by

Part D drugs prescribed in 2019

Januvia	66	$49,159	$745
Victoza 3-Pak	26	$26,784	$1,030
Lantus Solostar	20	$13,663	$683
Humalog Kwikpen U-100	15	$12,231	$815
Jardiance	22	$10,658	$484
Tresiba Flextouch U-100	17	$6,483	$381
Risedronate	24	$4,736	$197
Basaglar Kwikpen U-100	15	$4,654	$310
Synthroid	64	$4,299	$67
Repaglinide	44	$2,939	$67
Ultra-Fine Nano Pen Needle	24	$2,354	$98
Levothyroxine	57	$1,156	$20
Liothyronine	20	$798	$40
Atorvastatin	29	$532	$18
Metformin	39	$455	$12
Metformin Hcl Er	15	$299	$20
Levoxyl	11	$194	$18
Lisinopril	16	$176	$11
Losartan	20	$115	$6

2018: 20 drugs

Sort by

Part D drugs prescribed in 2018

Januvia	55	$37,158	$676
Lantus Solostar	34	$22,884	$673
Humalog Kwikpen U-100	24	$14,921	$622
Victoza 3-Pak	12	$10,983	$915
Victoza 2-Pak	17	$10,418	$613
Farxiga	15	$9,591	$639
Tradjenta	15	$9,484	$632
Basaglar Kwikpen U-100	21	$6,328	$301
Repaglinide	48	$4,305	$90
Tresiba Flextouch U-100	14	$3,950	$282
Synthroid	36	$3,553	$99
Ultra-Fine Nano Pen Needle	28	$1,599	$57
Levothyroxine	57	$1,424	$25
Ultra-Fine Mini Pen Needle	18	$1,160	$64
Atorvastatin	36	$718	$20
Ultra-Fine Short Pen Needle	12	$551	$46
Metformin	38	$430	$11
Fludrocortisone Acetate	14	$343	$25
Levoxyl	26	$329	$13
Glimepiride	13	$139	$11

2017: 18 drugs

Sort by

Part D drugs prescribed in 2017

Januvia	60	$38,444	$641
Lantus Solostar	32	$17,363	$543
Tradjenta	26	$13,605	$523
Humalog Kwikpen U-100	19	$11,300	$595
Novolog Flexpen	13	$10,094	$776
Synthroid	37	$2,936	$79
Repaglinide	15	$1,633	$109
Levothyroxine	40	$1,105	$28
Ultra-Fine Nano Pen Needle	21	$956	$46
Isosorbide Dinitrate	12	$590	$49
Atorvastatin	29	$472	$16
Metformin	38	$385	$10
Methimazole	17	$377	$22
Glimepiride	22	$224	$10
Hydralazine	12	$135	$11
Carvedilol	12	$86	$7
Clopidogrel	12	$86	$7
Furosemide	12	$86	$7

2016: 12 drugs

Sort by

Part D drugs prescribed in 2016

Januvia	54	$27,256	$505
Lantus Solostar	28	$14,135	$505
Tradjenta	17	$8,776	$516
Risedronate	15	$2,671	$178
Synthroid	33	$2,347	$71
Bd Ultra-Fine Pen Needle	41	$1,752	$43
Repaglinide	24	$1,397	$58
Levothyroxine	41	$963	$23
Alendronate	15	$625	$42
Metformin	53	$456	$9
Atorvastatin	22	$349	$16
Methimazole	30	$275	$9

2015: 9 drugs

Sort by

Part D drugs prescribed in 2015

Januvia	40	$20,063	$502
Lantus Solostar	18	$9,496	$528
Tradjenta	17	$5,542	$326
Lantus	11	$4,285	$390
Bd Ultra-Fine Pen Needle	31	$1,357	$44
Synthroid	26	$1,311	$50
Levothyroxine	30	$703	$23
Metformin	52	$430	$8
Atorvastatin	16	$264	$16

2014: 6 drugs

Sort by

Part D drugs prescribed in 2014

Januvia	40	$15,577	$389
Humalog	11	$3,682	$335
Levothyroxine	22	$475	$22
Metformin	32	$279	$9
Atorvastatin	15	$237	$16
Glimepiride	11	$42	$4

Money from drug and device companies

$39 in 2022

Sort by

Industry payments by year

2022	2	2	None	$39
2021	3	3	None	$66
2019	11	22	None	$718

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

AstraZeneca Pharmaceuticals LP	Farxiga	$20	1 payment Meals for Farxiga · 2022-09-23 · $20
Mannkind	Afrezza	$19	1 payment Meals for Afrezza · 2022-04-22 · $19

See all 2 published payments

Sort by

Every published payment

AstraZeneca Pharmaceuticals LP	Meals · 2022-09-23	Farxiga	$20
Mannkind	Meals · 2022-04-22	Afrezza	$19

See earlier years (2021, 2019)

2021: $66

Sort by

Payments by company in 2021

Amgen	Evenity	$32	1 payment Meals for Evenity · 2021-09-28 · $32
AstraZeneca Pharmaceuticals LP	Farxiga	$18	1 payment Meals for Farxiga · 2021-01-14 · $18
Novo Nordisk	Ozempic	$16	1 payment Meals for Ozempic · 2021-04-08 · $16

2019: $718

Sort by

Payments by company in 2019

Companion Medical	Inpen	$189	3 payments Meals for Inpen · 2019-08-06 · $30 Meals for Inpen · 2019-06-13 · $34 Meals for Inpen · 2019-05-01 · $126
Boehringer Ingelheim Pharmaceuticals	Tradjenta	$125	5 payments Education for Jardiance · 2019-07-19 · $7 Meals for Jardiance · 2019-07-19 · $28 Meals for Jardiance · 2019-05-02 · $24 Meals for Tradjenta · 2019-04-05 · $34 Meals for Tradjenta · 2019-03-18 · $32
Medtronic MiniMed	Minilink Real-Time Transmitter	$110	1 payment Meals for Minilink Real-Time Transmitter · 2019-09-05 · $110
Mannkind	Afrezza	$96	3 payments Gift for Afrezza · 2019-09-10 · $59 Meals for Afrezza · 2019-08-26 · $21 Meals for Afrezza · 2019-05-24 · $16
Merck Sharp & Dohme	Januvia	$47	3 payments Meals for Pneumovax 23 · 2019-09-25 · $14 Meals for Januvia · 2019-06-05 · $18 Meals for Januvia · 2019-03-06 · $16
Lilly USA	Trulicity	$39	2 payments Meals for Glyxambi · 2019-08-31 · $18 Meals for Trulicity · 2019-05-23 · $21
Insulet	Omnipod	$26	1 payment Meals for Omnipod · 2019-04-08 · $26
Novo Nordisk	Ozempic	$25	1 payment Meals for Ozempic · 2019-08-28 · $25
AstraZeneca Pharmaceuticals LP	Farxiga	$22	1 payment Meals for Farxiga · 2019-02-21 · $22
Sanofi-Aventis U.S.	Soliqua 100/33	$20	1 payment Meals for Soliqua 100/33 · 2019-03-13 · $20
AbbVie	Synthroid	$19	1 payment Meals for Synthroid · 2019-02-27 · $19

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Sort by

Research payments by company and study

Merck Sharp & Dohme Corporation · Tecos A Randomized, Placebo Controlled Clinical Trial To Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- Or Dual Combination Oral Antihyperglycemic Therapy · 2021	Their institution	$68
Merck Sharp & Dohme LLC · Tecos# A Randomized, Placebo Controlled Clinical Trial To Evaluate Cardiovascular Outcomes After Treatment With Sitagliptin in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control on Mono- Or Dual Combination Oral Antihyperglycemic Therapy · 2023	Their institution	$64

Professional record

NPI: 1457363830
Licence: CA A67095California A67095: Current · expires 2026-12-31
Trained: Emory University School of Medicine, 1994
Group: East Alabama Endocrinology, P.C.
Gender: Female

More record details

Sole proprietor: Yes
Taxonomy: Federal specialty code 207RE0101X (207RE0101X)
Mailing address: 50 E Hamilton Ave Ste 280, Campbell, CA, 95008
NPI first listed: 2006-08-13
NPI last updated: 2024-12-05
NPI record certified: 2024-12-05

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 1 Shrader St, San Francisco, CA, 94117 · Po Box 590065, San Francisco, CA, 94159 · 3883 Airway Dr Ste 201, Santa Rosa, CA, 95403